Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × copanlisib × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 6 Neoplasm Metastasis 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Multiple Myeloma 2 Lymphoma, Follicular 2 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Spinocerebellar Degenerations 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Renal Insufficiency 1 Recurrence 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Malignant Solid Neoplasm 1 Lymphoma, Mantle-Cell 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hepatic Insufficiency 1 Gallbladder Neoplasms 1 Digestive System Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

Gemcitabine 42 Cisplatin 29 pembrolizumab 25 Paclitaxel 12 Docetaxel 12 atezolizumab 11 Nivolumab 10 Mitomycin 10 avelumab 9 Carboplatin 9 Cystectomy 8 durvalumab 7 Sunitinib 7 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 apaziquone 5 Vinblastine 5 Platinum 5 Methotrexate 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4 vinflunine 3 tisotumab vedotin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡